Clive McCarthy

This inventor holds 24 USPTO granted patents and 2 published patent applications and 6 EPO patents. Top assignees: Novartis Ag, Enterprise Therapeutics Limited, Orca Pharmaceuticals Limited. Active years: 2007-2023.

USPTO Granted Patents = 24 (Patent Applications = 2)

% Patents Active = 33.3

EPO Patents = 6 (Patent Applications = 8)

Average Co-Inventor Count = 4.9

ph-index = 4

Forward Citations = 40(Granted Patents)

Location History:

Basel, CH (2007 - 2012)
Froidefontaine, FR (2013)
Horsham, GB (2014)
Oxfordshire, GB (2014 - 2018)
Brighton, GB (2020 - 2022)
Abingdon, GB (2013 - 2023)

Company Filing History:

Enterprise Therapeutics Limited

patents

3 out of 3

Orca Pharmaceuticals Limited

patents

Years Active: 2007-2023

Loading Chart...

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11739094 - Substituted benzodiazoliums as ENaC inhibitors (2023-08-29),

2. 11370778 - Bis(pentahydroxyhexyl)amino substituted 2-{[(3-amino-pyrazin-2-yl)formamido]methyl}-1H-1,3-benzodiazol-3-ium derivatives as ENaC inhibitors for treating respiratory diseases (2022-06-28),

3. 10941149 - Substituted benzodiazoliums as ENaC inhibitors (2021-03-09),

4. 10759785 - Compounds (2020-09-01),

5. 10383850 - Indazole and indole derivatives as inhibitors of retinoic acid related orphan receptor gamma (ROR gamma) for the treatment of immune-related diseases (2019-08-20),

6. 9861612 - Indolyl-containing RORγt inhibitors (2018-01-09),

7. 9522134 - Compounds (2016-12-20),

8. 9458177 - Oxazolidin-2-one compounds and uses thereof (2016-10-04),

9. 8865894 - Oxazolidin-2-one compounds and uses thereof (2014-10-21),

10. 8822468 - 3-Methyl-imidazo[1,2-b]pyridazine derivatives (2014-09-02),

11. 8614239 - Heterocyclic sulfonamide derivatives (2013-12-24),

12. 8466289 - Heterocyclic sulfonamide derivatives (2013-06-18),

13. 8389526 - 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives (2013-03-05),

14. 8129541 - 5-phenylthiazole derivatives and use as PI3 kinase inhibitors (2012-03-06),

15. 8039455 - Macrocyclic compounds useful as BACE inhibitors (2011-10-18),

Title: Clive McCarthy: Pioneering Inventor from Basel

Introduction: Clive McCarthy is a renowned inventor based in Basel, Switzerland, known for his groundbreaking contributions to various fields of technology and innovation.

Latest Patents: Clive McCarthy holds several patents in the areas of biotechnology, renewable energy, and artificial intelligence, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over three decades, Clive McCarthy has worked with leading research institutions and multinational companies to develop cutting-edge solutions that have had a significant impact on the industry.

Collaborations: Throughout his career, Clive McCarthy has collaborated with top scientists, engineers, and inventors from around the world, fostering a culture of innovation and knowledge sharing.

Conclusion: Clive McCarthy's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.